CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Art Pappas to sit on a panel titled "Venture Funding" at the EDC BioTech 2008 conference at in Miami, FL
News | 04. 24. 2008
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.